Portal de Periódicos da CAPES

Lupus tumidus induced by bortezomib not requiring discontinuation of the drug

2010; Wiley; Volume: 24; Issue: 11 Linguagem: Inglês

10.1111/j.1468-3083.2010.03643.x

1468-3083

I Aguayo‐Leiva, Sérgio Vañó-Galván, R Carrillo‐Gijon, Pedro Jaén‐Olasolo,

Drug-Induced Adverse Reactions

Journal of the European Academy of Dermatology and VenereologyVolume 24, Issue 11 p. 1363-1364 Lupus tumidus induced by bortezomib not requiring discontinuation of the drug I Aguayo-Leiva, Corresponding Author I Aguayo-LeivaCorrespondence: I Aguayo-Leiva. E-mail:[email protected]Search for more papers by this authorS Vano-Galvan, S Vano-Galvan Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this authorR Carrillo-Gijon, R Carrillo-Gijon Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this authorP Jaén-Olasolo, P Jaén-Olasolo Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this author I Aguayo-Leiva, Corresponding Author I Aguayo-LeivaCorrespondence: I Aguayo-Leiva. E-mail:[email protected]Search for more papers by this authorS Vano-Galvan, S Vano-Galvan Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this authorR Carrillo-Gijon, R Carrillo-Gijon Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this authorP Jaén-Olasolo, P Jaén-Olasolo Department of Dermatology, Hospital Ramón y Cajal, Carretera Colmenar Viejo Km 9.100, Madrid, SpainSearch for more papers by this author First published: 23 March 2010 https://doi.org/10.1111/j.1468-3083.2010.03643.xCitations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Sanchez-Politta S, Favet L, Kerl K, Dietrich PY, Piguet V. Bortezomib-induced skin eruption. Dermatology 2008; 216: 156–158. 10.1159/000111513 CASPubMedWeb of Science®Google Scholar 2 Böckle BC, Baltaci M, Weyrer W, Sepp NT. Bortezomib-induced lupus erythematosus tumidus. Oncologist 2009; 14: 637–639. 10.1634/theoncologist.2008-0197 PubMedWeb of Science®Google Scholar 3 Schmitt V, Meuth AM, Amler S et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol 2009; 162: 64–73. 10.1111/j.1365-2133.2009.09401.x PubMedWeb of Science®Google Scholar 4 Pour L, Hajek R, Zdenek A, Krejci M, Krivanova A, Vorlicek J. Skin lesions induced by bortezomib. Haematologica 2005; 90(12 Suppl.): ECR44. PubMedGoogle Scholar 5 Garcia-Navarro X, Puig L, Fernández-Figueras MT, Dalmau J, Roe E, Alomar A. Bortezomib-associated cutaneous vasculitis. Br J Dermatol 2007; 157: 799–801. 10.1111/j.1365-2133.2007.08073.x CASPubMedWeb of Science®Google Scholar 6 Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW. Bortezomib-induced histiocytoid Sweet syndrome. J Am Acad Dermatol 2009; 60: 496–497. 10.1016/j.jaad.2008.09.007 PubMedWeb of Science®Google Scholar 7 Schneider SW, Staender S, Schlüter B, Luger TA, Bonsmann G. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol 2006; 142: 115–116. 10.1001/archderm.142.1.115 PubMedWeb of Science®Google Scholar 8 Schepis C, Lentini M, Siragusa M, Batolo D. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and Lupus erythematosus tumidus. Dermatology 2004; 208: 354–355. 10.1159/000077849 PubMedWeb of Science®Google Scholar 9 Min CK, Lee S, Kim YJ et al. Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines. Eur J Haematol 2006; 76: 265–268. 10.1111/j.0902-4441.2005.t01-1-EJH2437.x CASPubMedWeb of Science®Google Scholar 10 Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev. 2009; 8: 456–461. 10.1016/j.autrev.2008.12.012 CASPubMedWeb of Science®Google Scholar Citing Literature Volume24, Issue11November 2010Pages 1363-1364 ReferencesRelatedInformation